Goal:In this review we aim to bring a little more about the therapeutic vision of acute viral bronchiolitis and the use of new therapies with monoclonal antibodies.Methods: An integrative review was carried out, using as criteria the search in the National Library of Medicine (PubMed) and Scientific Electronic Library Online (SciELO) databases using the descriptors (i) Acute viral bronchiolitis (ii) monoclonal antibodies, (iii) immunoprophylaxis, with the Boolean operator "AND".Studies published from 2019 to 2024 were included.Results: With the results that the therapy carried out for acute viral bronchiolitis is still under construction as we do not yet have specific therapies, however there are great future perspectives regarding the use of monoclonal antibodies such as Palivizumab.
No takes yet. Share an insight, caveat, or question.
Cappellesso et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: